González-Álvarez, H.; Bravo-Jiménez, A.; Martínez-Arellanes, M.; Gamboa-Osorio, G.O.; Chávez-Gutiérrez, E.; González-Hernández, L.A.; Gallardo-Ignacio, K.; Quintana-Romero, O.J.; Ariza-Castolo, A.; Guerra-Araiza, C.;
et al. In Silico-Based Design and In Vivo Evaluation of an Anthranilic Acid Derivative as a Multitarget Drug in a Diet-Induced Metabolic Syndrome Model. Pharmaceuticals 2021, 14, 914.
https://doi.org/10.3390/ph14090914
AMA Style
González-Álvarez H, Bravo-Jiménez A, Martínez-Arellanes M, Gamboa-Osorio GO, Chávez-Gutiérrez E, González-Hernández LA, Gallardo-Ignacio K, Quintana-Romero OJ, Ariza-Castolo A, Guerra-Araiza C,
et al. In Silico-Based Design and In Vivo Evaluation of an Anthranilic Acid Derivative as a Multitarget Drug in a Diet-Induced Metabolic Syndrome Model. Pharmaceuticals. 2021; 14(9):914.
https://doi.org/10.3390/ph14090914
Chicago/Turabian Style
González-Álvarez, Héctor, Astrid Bravo-Jiménez, Matilda Martínez-Arellanes, Gabriela Odette Gamboa-Osorio, Edwin Chávez-Gutiérrez, Lino A. González-Hernández, Karina Gallardo-Ignacio, Osvaldo J. Quintana-Romero, Armando Ariza-Castolo, Christian Guerra-Araiza,
and et al. 2021. "In Silico-Based Design and In Vivo Evaluation of an Anthranilic Acid Derivative as a Multitarget Drug in a Diet-Induced Metabolic Syndrome Model" Pharmaceuticals 14, no. 9: 914.
https://doi.org/10.3390/ph14090914
APA Style
González-Álvarez, H., Bravo-Jiménez, A., Martínez-Arellanes, M., Gamboa-Osorio, G. O., Chávez-Gutiérrez, E., González-Hernández, L. A., Gallardo-Ignacio, K., Quintana-Romero, O. J., Ariza-Castolo, A., Guerra-Araiza, C., Martino-Roaro, L., Meneses-Ruiz, D. M., Pinto-Almazán, R., & Loza-Mejía, M. A.
(2021). In Silico-Based Design and In Vivo Evaluation of an Anthranilic Acid Derivative as a Multitarget Drug in a Diet-Induced Metabolic Syndrome Model. Pharmaceuticals, 14(9), 914.
https://doi.org/10.3390/ph14090914
